IO Biotech, Inc. (IOBTQ) Accumulated Depreciation (2021 - 2025)

IO Biotech (IOBTQ) has 5 years of Accumulated Depreciation data on file, last reported at $776000.0 in Q3 2025.

• Quarterly Accumulated Depreciation rose 47.81% year-over-year to $776000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $776000.0 (up 47.81% YoY) and the FY2024 annual result came in at $577000.0, up 74.85% from the prior year.
• Accumulated Depreciation grew to $776000.0 in Q3 2025, from $726000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $776000.0 in Q3 2025 to a low of $12000.0 in Q4 2021.
• A 5-year average of $400384.6 and a median of $392000.0 in 2024 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation surged 858.33% — and 2025, when it soared 47.81%.
• Tracing IOBTQ's Accumulated Depreciation over 5 years: stood at $12000.0 in 2021, then surged by 858.33% to $115000.0 in 2022, then jumped by 186.96% to $330000.0 in 2023, then jumped by 74.85% to $577000.0 in 2024, then surged by 34.49% to $776000.0 in 2025.
• The last three Accumulated Depreciation figures came in at $776000.0 (Q3 2025), $726000.0 (Q2 2025), and $645000.0 (Q1 2025), per Business Quant data.